• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

This product is currently not available for purchase.


Antithrombotics Market Forecast Product Image

Antithrombotics Market Forecast

  • ID: 706637
  • December 2009
  • Datamonitor

The antithrombotics market, comprising anticoagulant and antiplatelet sectors, has grown steadily over the 200408 period to $17 billion. However, this has little to do with a raft of recent launches: Lovenox (enoxaparin, Sanofi-Aventis), Plavix (Sanofi-Aventis and Bristol-Myer's Squibb), warfarin and aspirin collectively occupy 78% of the market by volume, and 69% by value.

Key reasons to purchase this title

- Understand why PLATO and RE-LY stole the limelight at the European Society of Cardiology meeting in 2009.

- Quantify the impact of exclusivity rulings on both Lovenox and Plavix and their successors between now and 2018.

- Compare your views on key marketed and pipeline drugs against our independent drug overviews.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S